MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Genetics"

  • MDS Virtual Congress 2021

    Genetic features and long-term outcome of Korean patients with Huntington’s disease.

    YS. Hwang, SY. Jo, SH. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: To investigate the genetic characteristics and long-term outcome of Korean patients with Huntington’s disease. Background: Huntington’s disease is an autosomal dominant neurodegenerative disease, which…
  • MDS Virtual Congress 2021

    Cost of Predictive Genetic Testing for Huntington’s Disease at Centers of Excellence in the US

    M. Massey, T. Orem, V. Sung (Birmingham, USA)

    Objective: To characterize the cost of Huntington’s disease predictive genetic testing at Centers of Excellence in the US. Background: Despite the availability of predictive genetic…
  • MDS Virtual Congress 2021

    Risk and timing of manifest Huntington’s disease in patients with reduced penetrance alleles

    E. Mcdonnell, Y. Wang, K. Marder (New York, USA)

    Objective: To estimate risk of Huntington’s disease (HD) over time in patients with reduced penetrance (RP) alleles (36-39 CAG repeats) overall, by individual repeat length,…
  • MDS Virtual Congress 2021

    Quantifying Tremor in the R6/2 Mouse model of Huntington’s Diease

    H. Skelton, D. Grogan, J. Rubiano, R. Gross, C. Gutekunst (Atlanta, USA)

    Objective: To better characterize and precisely quantify the tremor widely observed in R6/2 mouse models of Huntington’s disease. Background: Tremor is a prominent feature of…
  • MDS Virtual Congress 2021

    Mobile application for assessing the likelihood of developing depression in patients with Parkinson’s disease

    M. Nikitina, A. Bragin, E. Bragina, V. Alifirova, N. Zhukova, D. Gomboeva, V. Spitsyn (Tomsk, Russian Federation)

    Objective: To develop a mobile application for assessing the likelihood of developing depression in patients with Parkinson's disease (PwPD), taking into account the number of…
  • MDS Virtual Congress 2021

    GNAO1 related movement disorders: 2 longitudinally-followed cases

    CC. Wang, S. Lee (Lebanon, USA)

    Objective: To describe the clinical course, phenomenology, and treatment response in two patients with GNAO1 related movement disorders. Background: Since the initial report of 4…
  • MDS Virtual Congress 2020

    Movement disorders associated with expansions and intermediate repeats in the C9orf72 gene

    C. Estevez-Fraga, F. Magrinelli, A. Latorre, S. Tabrizi, H. Houlden, K. Bhatia (London, United Kingdom)

    Objective: This work sought to investigate the frequency and characteristics of movement disorders (MD) associated with repeat expansions or intermediate repeats in the C9orf72 gene.…
  • MDS Virtual Congress 2020

    Genetic analysis of Huntington’s Disease in a Brazilian Amazonian population

    D. Brito, M. Della Coletta, G. Ferreira, L. Amorim, S. Souza, S. Peixoto, C. Rezende (Manaus, Brazil)

    Objective: Characterize genetically a series of cases of patients with Huntington’s disease and their family members at risk in the city of Manaus, capital of…
  • MDS Virtual Congress 2020

    Huntington’s disease in Egypt; A big challenge for a mysterious disease

    S. El-Jaafary, A. Sabbah, H. Amer (Cairo, Egypt)

    Objective: To identify the challenges of managing Huntington’s disease in Egypt in order to overcome them. Background: Huntington’s disease (HD) is considered a rare disease…
  • MDS Virtual Congress 2020

    Association between the number of CAG repetitions and cognitive performance in Huntington’s disease in patients of the National Institute of Neurology and Neurosurgery “MVS”

    D. Gasca-Saldaña, A. Vega-Rosas, G. Palma-Cordero, O. Castellanos-Maya (CDMX, Mexico)

    Objective: To establish the relationship between the number of CAG repetitions and the total Montreal Cognitive Assessment (MoCA) scores in patients with Huntington disease (HD).…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • #25136 (not found)
  • Unusual prolonged survival in multiple system atrophy: A case report
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley